(Q39468304)

English

IGF1/insulin receptor kinase inhibition by BMS-536924 is better tolerated than alloxan-induced hypoinsulinemia and more effective than metformin in the treatment of experimental insulin-responsive breast cancer

scientific article published on 14 November 2011

Statements

IGF1/insulin receptor kinase inhibition by BMS-536924 is better tolerated than alloxan-induced hypoinsulinemia and more effective than metformin in the treatment of experimental insulin-responsive breast cancer (English)
Carly Jade Dool
Haider Mashhedi
Mahvash Zakikhani
Stéphanie David
Yunhua Zhao
Elena Birman
Joan M Carboni
Marco Gottardis
Marie-José Blouin
Michael Pollak
14 November 2011
699-709

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit